BIOLASE Inc news

   Watch this stock
Showing stories 1 - 10 of about 103   

Articles published

BIOL 2.00 -0.01 (-0.50%)
price chart
Biolase management overhauled amid bid to stanch a decade of red ink
Biolase Inc., a manufacturer and distributor of dental lasers, is pinning its turnaround hopes on a new management team. Biolase develops, manufactures and markets laser systems that are used in dental procedures.
Related articles »  
Oracle Partners Decisively Wins Shareholder Litigation Against Biolase, Inc.
GREENWICH, Conn., Jun 13, 2014 (BUSINESS WIRE) -- Oracle Partners, L.P. ("Oracle Partners"), Biolase, Inc.
Related articles »  
BIOLASE Inc Short Interest Update
The short interest in BIOLASE Inc (NASDAQ:BIOL) has declined from 3,232,700 on January 30,2015 to 3,156,728 on February 13,2015.
Healthcare Stocks In The Spotlight: BIOLASE, (NASDAQ:BIOL), AmSurg ...
BIOLASE, Inc. (NASDAQ:BIOL)'s shares picked up 5.85%, and closed at $2.17, during the last trading session, soon after the news release that a medical technology company, introduced dentistry's first-ever Practice Growth Guarantee with the launch of ...
Small Caps Attracting Some Extra Attention - Servicesource International ...  Wall Street Observer
BIOLASE Inc (BIOL): Biolase: What Will Happen Next ?
Two days ago I highlighted an ongoing plunge that had already begun at Biolase (NASDAQ:BIOL). Prior to my article, the shares had already dropped by 50% in a few days due to the markets' concern over Biolase's solvency and an upcoming financing.
Related articles »  
Oracle Partners Announces Its Proxy Contest Against Biolase, Inc.
GREENWICH, Conn., March 11, 2014 /PRNewswire/ -- Oracle Partners, L.P. ("Oracle"), Biolase, Inc.'s ("Biolase" or the "Company") (Nasdaq: BIOL) largest shareholder, announces its nomination of four independent directors for election to the Biolase Board ...
BIOLASE Inc (BIOL) news: Biolase management faces proxy fight  Seeking Alpha
Related articles »  
BIOLASE Inc (BIOL): Biolase: Management's Statements At Odds With The Facts
Management of Biolase (NASDAQ:BIOL) has repeatedly tried to mask bad news through the use of euphemistic and creative wording in disclosures and press releases.
Related articles »  
Biolase, Inc. (NASDAQ:BIOL) Update: BIOLASE names David Dreyer CFO
Biolase, Inc. (NASDAQ:BIOL) Updated based on the information released on Monday, Mar 2nd, BIOLASE names David Dreyer CFO.
BIOLASE (BIOL) Set to Announce Earnings on Wednesday  WKRB News
Biolase (BIOL) Reports $35M Private Placement
BIOLASE, Inc. (NASDAQ: BIOL), the world's leading dental laser manufacturer and distributor, announced today that investors including Jack W. Schuler, Oracle Partners, L.P.
BIOLASE to Raise $35 Million from Institutional and Individual Investors in ...  MarketWatch
BIOLASE Reports 2014 Third Quarter Results  Business Wire (press release)
Related articles »  
Update on Biolase - Oracle Partners fight for control (BIOL)
The Vice Chancellor of the Court of Chancery of the State of Delaware rules that shareholder Oracle Partners-backed Paul Clark's February 28, 2014 election to the board of directors is valid.
Oracle Partners Announces a Victory in Shareholder Litigation Against ...  MarketWatch
Related articles »